A clinical trial in subjects who suffer from hay fever to see the effects of the study medication, SB-705498, when taken on its own or in conjunction with a background therapy, Fluticasone Propionate, on the symptoms triggered by an allergen challenge chamber session.
- Registry ID
- EUCTR2011-000115-11
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- GlaxoSmithKline Research and Development Ltd
- Start date
- 2011-04-19
- Completion date
- 2011-07-07
- Last update
- 2026-08-16
Conditions
Summary
Effect of 8 day treatment with intranasal SB-705498 on nasal symptoms elicited by an allergen chamber challenge in subjects with allergic rhinitis when co-administered with FP, compared to FP alone.
Effect of 8 day treatment with intranasal SB-705498 on nasal symptoms elicited by anallergen chamber challenge in subjects with allergic rhinitis compared to placebo.
Locations
View on source registry